ArticleVeterinary world2026
Dietary 5-aminolevulinic acid modulates gut microbiota, reduces oxidative stress, and enhances immune status in weanling piglets: An 8-week exploratory study.
Article in Veterinary world, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Five-aminolevulinic acid (5-ALA), a precursor in heme biosynthesis, has gained attention as a functional feed additive due to its reported benefits on metabolism, redox balance, and immunity. Although supplementation in sows and broilers has demonstrated favorable physiological outcomes, its effects on the gut microbiota and immune-oxidative profiles of weanling piglets remain unclear. This study aimed to evaluate whether 5-ALA supplementation modifies fecal microbiota composition and influences oxidative stress and immune parameters in piglets during the post-weaning period. Materials and Methods: Twelve 28-day-old piglets were randomly allocated to a control or 5-ALA group (20 mg/kg feed) for 56 days. Body weight (BW), fecal samples, and blood samples were collected at 28, 56, and 84 days of age. Fecal microbiota was characterized by 16S rRNA sequencing (QIIME2). Oxidative stress and inflammatory markers in leukocytes (superoxide radical, hypochlorite ion) were quantified using a dual chemiluminescence/fluorescence system. Plasma malondialdehyde (MDA) and immunoglobulin G (IgG) were measured to assess systemic oxidative damage and humoral immunity. Statistical analyses included Permutational Multivariate Analysis of Variance, LEfSe, and Spearman correlations. Results: BW did not differ significantly between groups, although the 5-ALA group tended to be heavier at 56 days. β-diversity differed significantly between groups at 56 and 84 days. Six and eight bacterial genera were differentially abundant at 56 and 84 days, respectively; 5-ALA supplementation enriched short-chain fatty acids-associated genera such as Conclusion: Dietary supplementation with 5-ALA altered the fecal microbiota and improved oxidative and immune status in weanling piglets, suggesting functional modulation of the gut-immune axis. Although exploratory and based on a small cohort, the findings warrant further controlled studies to validate dose-response effects and elucidate mechanistic pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.